Form 4: Director E. Thomas Corcoran Increases Stake in PAHC

Phibro Animal Health Corporation Director E. Thomas Corcoran purchased 10,000 shares of Class A Common Stock.

Summary

• Director E. Thomas Corcoran acquired 10,000 shares of Phibro Animal Health Corp (PAHC) Class A Common Stock.
• The purchase was executed on May 29, 2026, at a weighted average price of $31.77 per share.
• The transaction price ranged from $31.66 to $31.85 per share.
• Following this transaction, the director's total beneficial ownership increased to 41,459 shares.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal, as director-level insider buying typically indicates confidence in the company's future prospects.

Positives

• Insider confidence is demonstrated by the director's open-market purchase of company stock.
• The purchase reflects a commitment to the company's long-term value by a member of the board.

Negatives

• None identified in this filing.

Risks

• None identified in this filing.

Future Outlook

Not applicable as this is an insider transaction report.

Industry Context

StockSavvy.ai notes that insider buying is generally viewed as a positive signal by the market, suggesting that those with the most intimate knowledge of the company's operations believe the stock is undervalued or poised for growth.

Comparison to Industry Standards

• Insider purchases by board members are standard corporate governance activities and align with typical market behavior for publicly traded companies in the animal health sector.

Stakeholder Impact

• Shareholders may view this as a vote of confidence in the company's current strategic direction.

Key Dates

Keywords

Phibro Animal Health, PAHC, Insider Trading, Form 4, Director Purchase, Stock Acquisition